Lundbeck
HLUN-B.CO
#2414
Rank
NZ$10.34 B
Marketcap
$10.84
Share price
0.09%
Change (1 day)
33.89%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Market capitalization of Lundbeck (HLUN-B.CO)

Market cap: NZ$10.34 Billion

As of November 2024 Lundbeck has a market cap of NZ$10.34 Billion. This makes Lundbeck the world's 2414th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lundbeck from 2005 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$10.34 B39.1%
2023NZ$7.43 B30.67%
2022NZ$5.69 B466.11%
2021NZ$1.00 B-21.28%
2020NZ$1.27 B-15.19%
2019NZ$1.50 B-13.19%
2018NZ$1.73 B-8.79%
2017NZ$1.90 B21.49%
2016NZ$1.56 B17.52%
2015NZ$1.33 B97.39%
2014NZ$0.67 B-16.84%
2013NZ$0.81 B72.82%
2012NZ$0.46 B-44.49%
2011NZ$0.84 B31.35%
2010NZ$0.64 B-4.73%
2009NZ$0.67 B-34.81%
2008NZ$1.03 B8.52%
2007NZ$0.95 B-12.93%
2006NZ$1.09 B21.22%
2005NZ$0.90 B